{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T09:03:31Z","timestamp":1748941411705},"reference-count":0,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Oncol"],"DOI":"10.3892\/ijo.2011.1286","type":"journal-article","created":{"date-parts":[[2011,12,7]],"date-time":"2011-12-07T13:51:00Z","timestamp":1323265860000},"source":"Crossref","is-referenced-by-count":4,"title":["A phase II study of docetaxel weekly in combination with carboplatin every three weeks as first line chemotherapy in stage IIB-IV epithelial ovarian cancer: Neurological toxicity and quality-of-life evaluation"],"prefix":"10.3892","author":[{"given":"Bengt","family":"Sorbe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2011,12,7]]},"container-title":["International Journal of Oncology"],"original-title":[],"link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2011.1286\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T09:43:34Z","timestamp":1493286214000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ijo.2011.1286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,7]]},"references-count":0,"URL":"https:\/\/doi.org\/10.3892\/ijo.2011.1286","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,7]]}}}